Cargando…
Transcriptomic analysis reveals novel age-independent immunomodulatory proteins as a mode of cerebroprotection in P2X4R KO mice after ischemic stroke
Identification of new potential drug target proteins and their plausible mechanisms for stroke treatment is critically needed. We previously showed that genetic deletion and short-term pharmacological inhibition of P2X4R, a purinergic receptor for adenosine triphosphate ATP, provides acute cerebropr...
Autores principales: | Gamiotea-Turro, Daylin, Cronin, Chunxia C, Liang, Bruce T, Verma, Rajkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081441/ https://www.ncbi.nlm.nih.gov/pubmed/37034723 http://dx.doi.org/10.21203/rs.3.rs-2747807/v1 |
Ejemplares similares
-
Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapy
por: Arul, Michael R., et al.
Publicado: (2023) -
Evolving Clinical–Translational Investigations of Cerebroprotection in Ischemic Stroke
por: Li, Yinghui, et al.
Publicado: (2023) -
Comparative Cerebroprotective Potential of d- and l-Carnosine Following Ischemic Stroke in Mice
por: Jain, Saurabh, et al.
Publicado: (2020) -
Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection
por: Durukan, Aysan, et al.
Publicado: (2010) -
Ischemic postconditioning confers cerebroprotection by stabilizing VDACs after brain ischemia
por: Yao, Gui-Ying, et al.
Publicado: (2018)